c

Nice | Rivaroxaban in Acute Coronary Syndrome (ACS)

27th May 2015 by Louise Hudman

Nice | Rivaroxaban in Acute Coronary Syndrome (ACS)

This new guideline from Nice states that rivaroxaban can now be used after ACS with elevated cardiac enzymes. It should be used either with aspirin, or with aspirin and clopidogrel together.

  • It decreases the combined end points of MI, CVA or deaths from cardiovascular events by 20%.
  • There is a 3 x increased risk of major bleeding, so bleeding risk must be assessed.
  • Use beyond 12m hasn’t been studied, so use beyond that point is for clinical judgement.

It is generally started about a week after the event, so it is likely that we will be starting it, though hopefully it will be advised in the discharge summary.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"I have been a member of the NASGP for the past nine years and have found the advice and support offered invaluable. NASGP passionately champions for safe and fair working conditions for locums, which is crucial in an age of increasing medical litigation.

LocumDeck is a must for every locum who just wants to get on with the job that they were trained to do."

Dr Fiona Munro, GP

Dr Fiona Munro, GP

See the full list of features within our NASGP membership plans

Membership